Genmab A/S Sponsored ADR - 54 Year Dividend History | GMAB
Historical dividend payout and yield for Genmab A/S Sponsored ADR (GMAB) since 1971. The current TTM dividend payout for Genmab A/S Sponsored ADR (GMAB) as of February 21, 2025 is $0.00. The current dividend yield for Genmab A/S Sponsored ADR as of February 21, 2025 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$14.784B |
$3.122B |
|
Genmab A/S is a biotechnology company. It specializes in development of antibody therapeutics for the treatment of cancer. The company's product pipeline includes DARZALEX(R), Arzerra(R), tisotumab vedotin, enapotamab vedotin, HexaBody-DR5/DR5(R) and DuoBody-CD3xCD20 (R),which are in clinical stage. Genmab A/S is based in Copenhagen V, Denmark.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
